| An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/− mice | |||||||||||||
Abstract | |||||||||||||
| PTEN phosphatase acts as a tumor suppressor by negatively regulating the phosphoinositide 3-kinase (PI3K) signaling pathway. It is unclear which downstream components of this pathway are necessary for oncogenic transformation. In this report we show that transformed cells of PTEN+/− mice have elevated levels of phosphorylated Akt and activated p70/S6 kinase associated with an increase in proliferation. Pharmacological inactivation of mTOR/RAFT/FRAP reduced neoplastic proliferation, tumor size, and p70/S6 kinase activity, but did not affect the status of Akt. These data suggest that p70/S6K and possibly other targets of mTOR contribute significantly to tumor development and that inhibition of these proteins may be therapeutic for cancer patients with deranged PI3K signaling. | |||||||||||||
Publication details | |||||||||||||
| |||||||||||||
Publications citing this publication (1) | |||||||||||||
| |||||||||||||